After our euphoric news yesterday the questions across the dinner table last night were:
1. When will Mesoblast begin rolling out Remestemcel-L?
2. Where will they look to distribute this first? Will these be the hospitals that assisted with the trial or are there more potent avenues? Will there be a demographic style discussion of where the greatest good can be done?
3. how will they distribute the drug? Do they have a distribution network to enable fast roll out? Do they have sufficent stock to facilitate a broad sweep or will they target the hospitals that provide the best chance of gaining a foothold against ARDS?
Understanding that there are lives at stake and we have a chance to make an impact against ARDS, these questions have both humaitarian / philanthropic and financial leaning.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)